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Introduction
De-escalation of broad-spectrum antibiotics such as
anti-pseudomonal beta-lactams is recommended to
reduce antimicrobial selection pressure.
Objectives
To identify factors associated with de-escalation of anti-
pseudomonal beta-lactams in the Intensive Care Unit
(ICU). To assess whether de-escalation was associated
with outcome as measured by ICU mortality and acqui-
sition of MDR-pathogens.
Methods
We retrospectively included all ICU episodes in Ghent
University Hospital during 2013 and 2014 with prescrip-
tion of meropenem, piperacillin-tazobactam or ceftazi-
dime for at least 48 hours, stratifying between ICU
episodes of < and ≥4 days; for outcome analysis, only
the first ≥4 days episode per patient was included. De-
escalation was defined as a change from meropenem to
a non-carbapenem antibiotic other than colistin or ami-
noglycosides or a change from ceftazidime or piperacil-
lin-tazobactam to a non anti-pseudomonal antibiotic.
Organ failure improvement was defined as a decrease of
the SOFA score between day 3 and day 1 of the infection
for which the beta-lactam was prescribed. Antibiotics were
considered appropriate if they covered all etiologic patho-
gens of the infection. Multidrug-resistant (MDR) pathogens
were defined according to Magiorakos et al. (1). Acquisi-
tion of MDR pathogens was defined as the identification of
MDR pathogens more than 2 days after the start of the
antibiotic under study and not present before this date.
Results
Anti-pseudomonal beta-lactam antibiotics (n = 609)
were de-escalated in 23%: meropenem (n = 129) in 33%
and piperacillin-tazobactam (n = 453) or ceftazidime
(n = 27) in 20% (combined). De-escalation was not asso-
ciated with the focus or severity of infection, but was
significantly associated with organ failure improvement
(p = 0.03) and with the identification of etiologic patho-
gens (p < 0.001). Total antibiotic duration in infections
with and without de-escalation was 7 and 5 days,
respectively (p < 0.001). In multivariable analysis exam-
ining the relationship between ICU-mortality and de-
escalation with adjusment for organ failure improvement
and focus and severity of infection, ICU mortality was
not associated with de-escalation. Acquisition of MDR
was not significantly different in episodes with or with-
out de-escalation (33% versus 32%, p= 0.87).
Conclusions
De-escalation was associated with availability of etiologic
microbiological cultures and improvement of the SOFA
score. De-escalation was not associated with ICU mor-
tality or with the acquisition of MDR pathogens.
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